Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (5): 862-866    DOI: 10.12892/ejgo4577.2019
Case Report Previous articles | Next articles
Primary Burkitt lymphoma presenting as ovarian tumor rupture: a case report and literature review
X. Xu1, L. Zheng1, B. Xue3, M. Yao2, Y. Xu1, *()
1Department of Obstetrics and Gynecology, Jilin University Second Hospital, Jilin University, Changchun, China
2Department of Pathology, Jilin University Second Hospital, Jilin University, Changchun, China
3College of Basic Medical Sciences, Jilin University, Changchun, China
Download:  PDF(2405KB)  ( 112 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

A 16-year-old female presented with extreme lower abdominal pain, increasingly severe distension of abdomen, and difficulty breathing after strenuous exercise in the past eight days. Emergency exploratory laparotomy was performed and a large right ovarian tumor with rupture in the back of the tumor and active hemorrhage was seen. Final pathologic report suggested ovarian Burkitt lymphoma (BL). The patient recovered very well after the surgery and was referred to the oncology unit for further chemotherapy.

Key words:  Burkitt lymphoma      Ovarian tumor      Chemotherapy     
Published:  10 October 2019     
*Corresponding Author(s):  Y. XU     E-mail:  30245188@qq.com

Cite this article: 

X. Xu, L. Zheng, B. Xue, M. Yao, Y. Xu. Primary Burkitt lymphoma presenting as ovarian tumor rupture: a case report and literature review. European Journal of Gynaecological Oncology, 2019, 40(5): 862-866.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4577.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I5/862

[1] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[2] Jisu Yeom, Seulki Lee, Youngsun Kim. Hypercalcemia associated with primary mucinous ovarian tumor followed by pseudomyxoma peritonei can be fatal: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 824-827.
[3] Yanan Li, Dongge Wang, Xiaodong Li, Wangchao Zhang, Xianghua Huang, Yibin Liu. Appendix invasion of squamous cell carcinoma arising from ovarian mature cystic teratoma and resistant to combination chemotherapy with docetaxel and oxaliplatin: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 841-844.
[4] Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.
[5] Adrius Gaurilcikas, Migle Gedgaudaite, Saulius Paskauskas, Tomas Birzietis, Daiva Vaitkiene. Unusual case of Krukenberg tumors diagnosed in early pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 806-809.
[6] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[7] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[8] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[9] S.R Oh, J.-W. Park. Is the Risk of Malignancy Index a predictive tool for preoperative differentiation between borderline ovarian tumor and ovarian cancer?[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 368-374.
[10] T. Shoji, E. Takatori, M. Kagabu, M. Futagami, Y. Yokoyama, H. Tokunaga, N. Yaegashi, T. Ohta, T. Watanabe, T Sugiyama. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 380-385.
[11] H. Ishibashi, M. Miyamoto, T. Aoyama, H. Soyama, H. Matsuura, H. Iwahashi, M. Takano, K. Furuya. The effect of six scheduled cycles of neoadjuvant chemotherapy on prognosis in advanced ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 386-390.
[12] X.F. Xu, Q. Li, A.Y. Dai, H.J. Zhou, J.X. Ling. Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 489-491.
[13] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[14] T. Armeanu, R. Maftei, G. Simionescu, D. Nicolaiciuc, N. Plopa, B. Doroftei. Infertility and borderline malignant ovarian tumors: a case of successful pregnancy after fertility-preserving management of the disease[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 284-288.
[15] Y. S. Lee, J. M. Baek, E. K. Park, C. J. Kim, H. J. Lee, J. O. Kim. Expression and therapeutic potential of macrophage migration inhibitory factor and CD74 in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 65-69.
No Suggested Reading articles found!